Immunohistochemicalassessement of cellular proliferation versus tumor progression of squamous cell carcinoma of head and neck Introduction

CLINICOPATHOLOGICAL SIGNIFICANCE OF PROGRAMED DEATH -LIGAND -1(PD-L1) AND PROLIFERATION CELL NUCLEAR ANTIGE(PCNA)EXPRESSION IN PROSTATIC CARCINOMA; AN IMMUNOHISTOCHEMICAL STUDY"

p16INKa and Ki67 expression in different grades of cervical intraepithelial neoplasm in relation to HPV genotypes

p63 & ki67 antigen expression in relation to the aggressiveness of oral squamous cell carcinoma

Assessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics

Role of P16, P53 and Cyclin D1 in Detection of HPV Induced Laryngeal Squamous Cell Carcinoma: An Immunohistochemical Study

Prognostic significance of peroxisome proliferator-activated receptor-gamma (PPAR-γ) and Cyclin D1 in bladder urothelial carcinoma

IMMUNOHISTOCHEMICAL EXPRESSION OF P16 IN CERVICAL AND URINARY BLADDER SQUAMOUS CELL CARCINOMA

Evaluation Of clinical and malignancy grading of Oral squamous cell carcinoma based on an immunohistochemical study of stem cell marker CD133

Evaluation of the diagnostic performance of serum P53 protein for the diagnosis of colorectal cancer.